Navigation Links
Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
Date:9/19/2008

NEW YORK, Sept. 19 /PRNewswire/ -- Aerolase, the manufacturer of medical aesthetic lasers, announced today that it has retained SMH Capital Inc., a subsidiary of Sanders Morris Harris Group (Nasdaq: SMHG), as its financial advisor to explore financing alternatives to fund expansion into new markets.

The additional funding will be primarily directed toward expanding the Aerolase sales channel expansion into the market of about 300,000 U.S. primary care practitioners. This physician group is actively adding medical aesthetics to their practices to serve continuing strong demand for cosmetic-rejuvenation procedures, especially from affluent baby boomers.

"This is a unique opportunity for Aerolase," said CEO Dr. Pavel Efremkin. "Many physicians are now starting their new medical aesthetic practice, and YAG laser device is a "must-have" or "first-to-buy" laser for any medical aesthetic practitioner. Our LightPod Neo, because of its unique versatility, pain-free performance and portability, is undeniably the best YAG laser for this new market. With the expansion funding we will make LightPod the best selling medical laser on the market."

"We see tremendous potential for dramatic growth as medical aesthetic practitioners learn about the benefits of the LightPod Neo," said Mitchell Stern, Managing Director of SMH Capital Inc. "Aerolase is poised to capture a significant share of the aesthetic laser market over the next six to 12 months with sufficient funds to support expansion."

About Aerolase

Aerolase Corporation, Tarrytown, NY, is a world leader in the miniaturization of high-powered medical lasers. This core technology has been commercialized in the fields of medical & aesthetic dermatology as well as capill
'/>"/>

SOURCE Aerolase
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
2. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
4. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
5. Dragon retains leading investor relations firm
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. SPO Medical Retains American Capital Ventures for Investor Relations Services
8. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
9. CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing
10. Insmed Retains RBC Capital Markets as Strategic Financial Advisor
11. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... On Thursday, September 11, 2014, the NASDAQ Composite ... finished the day 0.12% lower at 17,049.00, and the S&P ... based as seven out of ten sectors ended the session ... the day at 741.83, down 0.33%, while the index has ... coverage on the following equities: Exelixis Inc. (NASDAQ: ...
(Date:9/11/2014)... RURO, Inc., a leading laboratory ... and sample management solutions provider, announces the release ... on the most recent version of its Limfinity® ... seen mass adoption, especially from multi-license environment customers. ... brought an entirely new User Interface and version ...
(Date:9/11/2014)... Lab researchers believes it has uncovered the secret ... layers of transition metal dichalcogenide (TMDC) materials, the ... and photonic applications. , Using two-photon excitation ... one of the most promising of 2D materials, ... dark states energy states in which single ...
(Date:9/11/2014)... one atom thick sheet of carbon, can be randomly ... of graphene that could have a significant impact on ... it could provide an ultra-strong, non-corrosive coating for a ... solutions can be used to paint various surfaces ranging ... a simple chemical treatment, the resulting coatings behave like ...
Breaking Biology Technology:Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5Limfinity® Version 5.1 Available 2Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3Graphene paints a corrosion-free future 2
... Stock for Rights to Spinal Cells in Future, ... (Amex: CUR ), announces that Korean conglomerate, CJ,CheilJedang ... for the exclusive license to Neuralstem,s stem cell-products and,technology ... part of the agreement, CJ has purchased $2.5 million ...
... will support Phase 3 Trials for Crohn,s Disease, Pouchitis and ... ... 20 Ocera Therapeutics, a,biopharmaceutical company focused on the licensing, ... of,gastrointestinal and liver diseases, has announced the completion of a,$35.5 ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), today ... Pharmaceuticals GmbH (Merz) for sales,by Merz and its ... Alzheimer,s disease for the quarter ended September 30,2007. ... royalty payments on sales of Memantine by Merz ...
Cached Biology Technology:Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation 2Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation 3Ocera Therapeutics Closes $35.5 Million Series C Financing 2Ocera Therapeutics Closes $35.5 Million Series C Financing 3Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine 2
(Date:9/15/2014)... cognitive function may play roles in one,s musical aptitude, ... timbre, tone durations, and formal structure in music. , ... that extremes in musical aptitude (extreme capacity/no capacity) are ... having moderate aptitude. , "This is a typical feature ... and it is influenced to varying degrees by environmental ...
(Date:9/15/2014)... is no published account where hippopotamuses are demonstrably shown ... of water. But if they can,t swim, how did ... widely accepted models for the methods, patterns, and timing ... Cyprus, Crete, and Madagascar) may need to be reconsidered. ... the mainland are not currently supported by positive ...
(Date:9/15/2014)... is available in German . ... is straightforward: it doubles, divides in the middle and ... long assumed that cells of the same kind are ... Bulgheresi,s team, University of Vienna, revealed that two non-model ... perceivable by the naked eye. These findings have been ...
Breaking Biology News(10 mins):Think big! Bacteria breach cell division size limit 2
... A new study suggests that jewel scarab beetles find ... that creates the 3D effects for the blockbuster movie ... Texas, the jewel scarab species Chrysina gloriosa ... ability could provide the beetles with a tremendous advantage, ...
... Lovn Centre for Marine Sciences at the University of Gothenburg ... in the Gullmarsfjord north of Gothenburg. The bacterium has been ... marine research center. Researcher Matthias Obst from the ... at the Sven Lovn Centre for Marine Sciences, a new ...
... Boston, MA A tobacco company,s new, dissolvable ... but which in some cases resembles popular candies--could lead ... new study from the Harvard School of Public Health ... for Disease Control and Prevention (CDC) and the Food ...
Cached Biology News:Beetles stand out using 'Avatar' tech 2Tobacco company's new, dissolvable nicotine products could lead to accidental poisoning 2
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Biology Products: